Covalon Technologies Ltd.
CVALF
Price:
$2.36
Market Cap:
$79.90M
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access ...[Read more]
Industry
Biotechnology
IPO Date
2007-04-18
Stock Exchange
PNK
Ticker
CVALF
The Enterprise Value as of September 2024 (TTM) for Covalon Technologies Ltd. (CVALF) is 71.57M
According to Covalon Technologies Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.57M. This represents a change of 154.51% compared to the average of 28.12M of the last 4 quarters.
Covalon Technologies Ltd. (CVALF) Historical Enterprise Value (quarterly & annually)
How has CVALF Enterprise Value performed in the past?
The mean historical Enterprise Value of Covalon Technologies Ltd. over the last ten years is 47.02M. The current 71.57M Enterprise Value has changed 15.12% with respect to the historical average. Over the past ten years (40 quarters), CVALF's Enterprise Value was at its highest in in the June 2018 quarter at 180.54M. The Enterprise Value was at its lowest in in the September 2017 quarter at 855.62K.
Average
47.02M
Median
38.47M
Minimum
2.08M
Maximum
188.79M
Covalon Technologies Ltd. (CVALF) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Covalon Technologies Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.96%
Maximum Annual Enterprise Value = 188.79M
Minimum Annual Increase = -90.64%
Minimum Annual Enterprise Value = 2.08M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 26.89M | -49.54% |
| 2022 | 53.29M | 5.85% |
| 2021 | 50.34M | 0.57% |
| 2020 | 50.06M | -14.84% |
| 2019 | 58.78M | -68.87% |
| 2018 | 188.79M | 8.96% |
| 2017 | 2.08M | -90.64% |
| 2016 | 22.27M | 288.18% |
| 2015 | 5.74M | -52.13% |
| 2014 | 11.98M | 59.09% |
Covalon Technologies Ltd. (CVALF) Average Enterprise Value
How has CVALF Enterprise Value performed in the past?
The current Enterprise Value of Covalon Technologies Ltd. (CVALF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
43.51M
5-year avg
47.87M
10-year avg
47.02M
Covalon Technologies Ltd. (CVALF) Enterprise Value vs. Peers
How is CVALF’s Enterprise Value compared to its peers?
Covalon Technologies Ltd.’s Enterprise Value is greater than Biotron Limited (14.38M), greater than Bioasis Technologies Inc. (395.85K), greater than Mosaic ImmunoEngineering Inc. (8.29M), greater than Ceapro Inc. (15.45M), less than Cellectis S.A. (144.28M), greater than Resverlogix Corp. (20.51M), greater than Small Pharma Inc. (38.25M), less than Advanced Proteome Therapeutics Corporation (0), greater than ChitogenX Inc. (149.63K), greater than null (5.96M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 14.38M | $10.06M | |
| 395.85K | $291.93K | |
| 8.29M | $7.24M | |
| 15.45M | $13.31M | |
| 144.28M | $183.12M | |
| 20.51M | $13.83M | |
| 38.25M | $37.51M | |
| 0 | $149.63K | |
| 149.63K | $1.45M | |
| 5.96M | $0 |
Build a custom stock screener for Covalon Technologies Ltd. (CVALF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Covalon Technologies Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Covalon Technologies Ltd. (CVALF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Covalon Technologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Covalon Technologies Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Covalon Technologies Ltd. (CVALF)?
What is the 3-year average Enterprise Value for Covalon Technologies Ltd. (CVALF)?
What is the 5-year average Enterprise Value for Covalon Technologies Ltd. (CVALF)?
How does the current Enterprise Value for Covalon Technologies Ltd. (CVALF) compare to its historical average?